Panobinostat sensitizes AraC-resistant AML cells to the combination of azacitidine and venetoclax. Zhao J, Wu S, Wang D, Edwards H, et al. Biochem Pharmacol 2024;228:116065.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao J, Wu S, Wang D, Edwards H, et al. Panobinostat sensitizes AraC-resistant AML cells to the combination of azacitidine and venetoclax. Biochem Pharmacol 2024;228:116065.
PMID: 38373594